Find AI Tools
Atomwise logo

Atomwise

Accelerate drug discovery, reduce costs, and improve lives with AI-powered candidate selection for clinical trials.

Try Atomwise free
  • Free plan available
  • No credit card

What is Atomwise?

Atomwise uses artificial intelligence to accelerate drug discovery by predicting which molecular candidates are most likely to succeed in clinical trials. The platform analyses chemical structures and biological data to identify promising compounds early, helping pharmaceutical companies and research organisations reduce development time and costs. Rather than testing thousands of candidates through traditional methods, teams can focus their resources on the most viable options. This approach shortens the path from initial research to clinical application, potentially bringing treatments to patients faster.

Key features

AI-powered molecular candidate prediction

Analyses chemical structures to forecast success in clinical trials

Cost reduction

Identifies high-potential compounds early, reducing wasted spending on unlikely candidates

Integration with existing workflows

Works alongside current drug discovery processes and laboratory systems

Data-driven prioritisation

Ranks candidates by likelihood of clinical success based on learned patterns

Freemium access

Starter tier available at no cost for smaller projects or evaluation

Pros & cons

Advantages

  • Significantly reduces the number of compounds requiring expensive wet-lab testing
  • Speeds up the candidate selection phase, compressing timelines from years to months in some cases
  • Lowers overall drug development costs by focusing resources on higher-probability molecules
  • Accessible entry point via free tier for researchers and smaller organisations

Limitations

  • Effectiveness depends on quality and volume of input data; limited datasets may produce less reliable predictions
  • Requires integration with existing laboratory and informatics infrastructure, which can demand technical setup
  • AI predictions still need validation through traditional testing; cannot replace experimental confirmation

Use cases

Screening large compound libraries to identify top candidates for expensive clinical trials

Speeding up lead optimisation in small molecule drug development

Reducing R&D budgets by focusing laboratory resources on AI-ranked highest-potential compounds

Supporting academic research teams with limited budgets to prioritise which molecules to synthesise and test

Ready to try Atomwise?

Try Atomwise free

Pricing

Free

Free

Limited access to core prediction features; suitable for evaluation and small-scale projects

Paid Tiers

Custom pricing

Full platform access, higher prediction volume, priority support, and integration options for pharmaceutical companies and research organisations

Get started with Atomwise

Click through to Atomwise and start using it now.

Try Atomwise free
  • Free plan available
  • No credit card